Diaceutics and Experian introduced a clinician-targeting capability that pushes real-time diagnostic signals into existing media-buying workflows, featuring Diaceutics’ AI-driven diagnostic audiences accessible via Experian Marketing Services. The integration is designed to let life sciences marketers activate clinically informed segments without changing their current tools or identity-resolution processes.
The offering routes diagnostically derived segments through Experian’s data marketplace, onboarding tools and curated channels, with daily data refreshes and deterministic NPI-level mapping based on observed biomarker results and diagnostic workups. This reduces the need for custom onboarding and uses Experian’s identity graph so segments plug into standard activation paths.
For marketers, the change means campaigns can align with active treatment decision moments rather than retrospective signals, enabling faster optimization and more precise clinician engagement when lab results prompt therapy choices. The move reflects broader healthcare marketing trends toward real-time, clinically grounded targeting.
Diagnostic-Driven Targeting Audiences
Diaceutics & Experian Launch Its Diagnostic Audiences
Trend Themes
-
Real-time Diagnostic Targeting — Marketers gain access to clinician segments informed by live lab results, shifting engagement to moments when treatment decisions are being made.
-
Clinically-informed Audience Activation — The integration of AI-driven diagnostic audiences into existing ad stacks enables campaigns to be activated on medically relevant signals rather than retrospective proxies.
-
Deterministic Npi-level Identity Mapping — Daily refreshed mappings to NPIs provide precise clinician-level resolution that links observed biomarker results to individual prescribing and referral behaviors.
Industry Implications
-
Life Sciences Marketing — Campaign strategies increasingly center on aligning promotional outreach with clinicians’ active diagnostic and treatment workflows to influence therapy choice windows.
-
Healthcare Advertising Platforms — Adtech providers are incorporating clinical data feeds and identity graphs to support medically grounded segmentation and deterministic activation in programmatic channels.
-
Diagnostic Laboratories — Labs become pivotal data sources as their result flows enable near-real-time segmentation of clinicians and other care decision-makers based on observed test outcomes.